Plaqenil Role in Prevention of Age Related Macular Degeneration

Ziv Hospital

Status: Unknown

Conditions: Age Related Macular Degeneration

Study type: Observational

Funder types: Other

Identifiers

NCT01541449

ZIV-0061-11

Details and patient eligibility

About

The investigators think that there is a connection between the use of plaquenil and the prevention of Age related macular degeneration (AMD). The investigators believe that the use of plaquenil makes bruch's membrane thicker, thereby preventing Chroidal Neovascularization (CNV) growth.

Full description

the study is done by comparing to groups RA patients who take plaquenil Vs. group of patients who do not take plaquenil. after measuring the retina thickness we compare the avg. thickness of both groups.

Enrollment: 30 estimated patients

Sex: All

Ages: 20 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• all people who suffer from rheumatoid arthritis (RA) and use plaquenil

Exclusion criteria

• patients who did not complete follow-up

Trial design

30 participants in 2 patient groups

RA patients treated with plaquenil

Patients who do not use plaquenil